🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Symptomatic Congestive Heart Failure

Assessment of CCM in HF With Higher Ejection Fraction NCT05064709NA67 sites📍 Birmingham📍 Mesa📍 Mesa Impulse Dynamics · Tests: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System, OPTIMIZER™ Smart Mini System The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF NCT06973902n/a13 sites📍 Marcianise📍 Mercogliano📍 Sessa Aurunca Quovadis Associazione · Tests: Cardiac Contractility Modulation (CCM) implant Patient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation NCT07852221n/a5 sites📍 Zabrze📍 Bern📍 Basel Insel Gruppe AG, University Hospital Bern Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure NCT06929806Phase 31 site📍 Pasadena Pharmacosmos A/S · Tests: Ferric Derisomaltose Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure NCT06552637NA5 sites📍 Indianapolis📍 Tulsa📍 Philadelphia VisCardia Inc. · Tests: Synchronized Diaphragmatic Stimulation A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF) NCT07795814Phase 228 sites📍 Birmingham📍 Little Rock📍 Beverly Hills Edgewise Therapeutics, Inc. · Tests: EDG-15400 25 mg, Placebo to match EDG-15400 25 mg or 50 mg, EDG-15400 50 mg AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF NCT06793371Phase 226 sites📍 Fairhope📍 Tucson📍 Little Rock Cytokinetics · Tests: CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg), Placebo to match CK-4021586 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists NCT06033950Phase 3176 sites📍 Fairhope📍 Phoenix📍 Yuma Colorado Prevention Center · Tests: Finerenone, Placebo A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) NCT05489705n/a101 sites📍 Anchorage📍 Tucson📍 Little Rock Bristol-Myers Squibb · Tests: Mavacamten, Non-mavacamten symptomatic oHCM therapy Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults. NCT07464106n/a1 site📍 Stuttgart Robert Bosch Medical Center · Tests: Transcatheter edge-to-edge repair (TEER) A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart NCT06935370Phase 3594 sites📍 Beverly Hills📍 Covina📍 Encinitas Boehringer Ingelheim · Tests: vicadrostat, empagliflozin, Placebo Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate. NCT06705023Phase 21 site📍 Astana Ralf Rothoerl · Tests: Uncultured, autologous, adipose-derived regenerative cells (UA-ADRCs), Continuation of patient's best guideline ba… HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management NCT07402239NA15 sites📍 Fuzhou📍 Lanzhou📍 Guangzhou United Innomed(Shanghai) Limited · Tests: NOVAtria System, Control Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation NCT06414265NA8 sites📍 Tbilisi📍 Tbilisi📍 Milan InnovHeart · Tests: Transcatheter mitral valve replacement Ablate and Pace HIS Study NCT06152406NA1 site📍 Leicester University Hospitals, Leicester · Tests: Ablation and Pacemaker Implantation Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction NCT06736574Phase 3209 sites📍 Alexander City📍 Birmingham📍 Tucson Cytokinetics · Tests: Omecamtiv Mecarbil (OM), Placebo A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure NCT06424288Phase 3665 sites📍 Mobile📍 Mobile📍 Chula Vista Boehringer Ingelheim · Tests: vicadrostat, empagliflozin, placebo A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD NCT07093528n/a1 site📍 Rochester Mayo Clinic · Tests: Cardiovascular Magnetic Resonance (CMR)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy